// App-Quantinova.ai

2913 : A Draft Modified Core Domain Set for Patient-Reported Outcomes (PRO) in Patients with Idiopathic Inflammatory Myopathies (IIM): An Omeract Report

Researchers

Presenter

  • Christopher A. Mecoli

Principal Investigators

  • Jin Kyun Park

  • Merrilee Needham

  • Ingrid De Groot

  • Catherine Sarver

  • Ingrid E. Lundberg

  • Beverly Shea

  • Marianne De Visser

  • Yeong Wook Song

  • Clifton O. Bingham III

  • Lisa Christopher-Stine

  • Helene Alexanderson

Medical Centers

  • Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden

  • Function Area Occupational Therapy and Physical Therapy, Karolinska University Hospital, Stockholm, Sweden

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Internal Medicine/Rheumatology, Johns Hopkins University, Baltimore, MD

  • Ophthalmology, Johns Hopkins University, Baltimore, MD

  • Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University, Seoul, Republic of Korea

  • Division of Rheumatology, Seoul National University Hospital, Seoul, Korea, Republic of (South)

  • Department of Molecular medicine and biopharmaceutical science, Seoul National University, seoul, Korea, Republic of (South)

  • Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Seoul, Republic of Korea

  • Division of Rheumatology, Seoul National University Hospital, Seoul, Korea, Republic of (South)

  • Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, seoul

  • Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Seoul, Republic of Korea

  • Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University, Seoul, Republic of Korea

  • Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University, Seoul, Republic of Korea

  • Curtin University, Perth, Australia.

  • patient research partner, Rotterdam, Netherlands

  • patient research partner, maryland, MD

  • Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden

  • Bruyere Research Institute, Ottawa, Ontario, Canada

  • Department of Heamatology, Cancer Center Amsterdam, Amsterdam, Netherlands

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Medicine/Pulmonology, Johns Hopkins University, Baltimore, MD

  • Department of NVS, Division of Physical Therapy, Karolinska Institutet, Huddinge, Stockholm, Sweden

Locations

  • Sweden

  • United States

  • Australia

  • Netherlands

  • Canada

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved